Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atorvastatin therapy for the prevention of atrial fibrillation (SToP-AF)

Trial Profile

Atorvastatin therapy for the prevention of atrial fibrillation (SToP-AF)

Phase of Trial: Phase III

Latest Information Update: 03 Aug 2018

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms SToP-AF
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 01 Apr 2011 Results published in the Journal of Cardiovascular Electrophysiology.
    • 01 Sep 2010 Results have been presented at the ESC Congress 2010: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top